Top Pharma Companies in India by Market Cap

BSE Sensex 74638.52 220.47 (-0.29%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
31	Jupiter Life Line Hospitals Ltd.	Q V PT	9,184 Small Cap	277.90 (0.69%)	48.23	5.72	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Park Medi World Ltd.	Q V PT	12,187 Small Cap	282.55 (-0.74%)	47.63	5.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Advanced Enzyme Technologies Ltd.	Q V PT	3,227 Small Cap	297 (1.04%)	41.06	4.55	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Medicamen Biotech Ltd.	Q V+ PT	448 Small Cap	328.95 (4.63%)	39.38	1.58	5.31	-13.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Tarsons Products Ltd.	Q V PT	1,631 Small Cap	332.65 (-2.16%)	163.05	2.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Marksans Pharma Ltd.	Q V+ PT	14,492 Small Cap	332.85 (-1.57%)	29.65	4.82	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Bajaj Healthcare Ltd.	Q V PT	1,108 Small Cap	338.50 (0.74%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Suven Life Sciences Ltd.	Q V+ PT	9,679 Small Cap	338.90 (0.21%)	N/A	17.16	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Artemis Medicare Services Ltd.	Q V+ PT	5,358 Small Cap	340.90 (0.83%)	47.09	5.97	21.50	83.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Suraksha Diagnostic Ltd.	Q V PT	1,750 Small Cap	354 (1.24%)	50.87	7.1	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	FDC Ltd.	Q V PT	5,746 Small Cap	358.60 (-1.09%)	19.96	2.25	9.91	0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	Indraprastha Medical Corporation Ltd.	Q V PT	3,326 Small Cap	365.60 (-0.42%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Syngene International Ltd.	Q V+ PT	14,905 Small Cap	377.30 (-2.09%)	67.99	3.34	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Panacea Biotec Ltd.	Q V+ PT	2,254 Small Cap	383.35 (2.00%)	N/A	2.75	0.55	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Biocon Ltd.	Q V PT	62,743 Mid Cap	391 (-1.01%)	658.88	2.35	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Ind-Swift Laboratories Ltd.	Q V+ PT	3,245 Small Cap	409.95 (7.44%)	57.88	2.22	-6.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Gujarat Themis Biosyn Ltd.	Q V PT	5,566 Small Cap	414.40 (0.00%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Aarti Drugs Ltd.	Q V PT	3,941 Small Cap	434.65 (-0.21%)	20.79	2.49	3.55	-6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Gufic Biosciences Ltd.	Q V PT	4,368 Small Cap	443 (1.68%)	59.48	6.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Cohance Lifesciences Ltd.	Q V+ PT	16,760 Small Cap	457.10 (-0.76%)	165.89	4.58	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
51	Fermenta Biotech Ltd.	Q V PT	1,400 Small Cap	473.70 (-0.13%)	23.08	3.38	6.85	5.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
52	SMS Pharmaceuticals Ltd.	Q V+ PT	4,148 Small Cap	485.45 (4.07%)	42.66	5.42	9.51	7.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
53	Dr. Agarwals Health Care Ltd.	Q V PT	15,845 Small Cap	492.05 (0.46%)	104.66	7.51	34.58	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
54	Amrutanjan Health Care Ltd.	Q V+ PT	1,427 Small Cap	501 (1.12%)	26.54	3.82	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
55	Sai Parenterals Ltd.	Q V PT	2,257 Small Cap	507.10 (-0.78%)	136.82	2.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
56	One Global Service Provider Ltd.	Q V+ PT	1,056 Small Cap	530.05 (-1.38%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
57	Unichem Laboratories Ltd.	Q V PT	3,841 Small Cap	550.70 (2.06%)	12.46	1.38	12.26	24.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
58	Krsnaa Diagnostics Ltd.	Q V PT	1,757 Small Cap	570.25 (2.71%)	18.48	1.82	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
59	Blue Jet Healthcare Ltd.	Q V PT	10,887 Small Cap	583.95 (0.75%)	46.7	4.9	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
60	Thyrocare Technologies Ltd.	Q V+ PT	8,848 Small Cap	589.15 (3.08%)	51.6	14.45	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	28.97	9.73%
Ind-Swift Labs.	409.95	7.44%
Aarti Pharmalabs	893	5.50%
Shukra Pharmaceut.	58.14	5.25%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Guj. Kidney & Super	175.95	-3.93%
Kopran	272.15	-3.85%
Kwality Pharma	3,700	-3.57%
Acutaas Chemicals	3,312.70	-3.20%
Concord Biotech	1,544.65	-2.28%

News about Top Pharma Companies in India

Sep, 2026

Park Medi World informs about press release

Pursuant to Regulation 30 of the Listing Regulations, Park Medi World has informed that it enclosed Press Release titled ‘Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026’. The above disclosure is also being made available on the website of the Company at https://www.parkhospital.in/.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

One Global Service Provider informs about corrigendum to AGM notice

In continuation of its intimation dated 5th September, 2026 regarding the Notice convening the 34th Annual General Meeting (‘AGM’) of the Company dated 3rd September, 2026 (‘AGM Notice’), scheduled to be held on Tuesday, 29th September, 2026 at 02:00 PM IST, One Global Service Provider has informed that a Corrigendum to the AGM Notice (‘Corrigendum’) is being sent today, Monday, 21st September, 2026, through email to the Members to whom the AGM Notice has been dispatched. The Corrigendum provides certain clarifications, modifications, and updates to the resolution and explanatory statement of Item No. 10 of the AGM Notice. A copy of the detailed Corrigendum is enclosed. The Corrigendum to the AGM Notice shall form an integral part of the AGM Notice, the AGM Notice shall always be read in conjunction with this Corrigendum. All other contents of the AGM Notice, save and except as modified or supplemented by Corrigendum, shall remain unchanged. The Corrigendum is also available on the website of the Company at www.1gsp.in and on the website of National Securities Depository Services at www.evoting.nsdl.com. The e-voting period commences on Friday, 25th September, 2026 (09.00 AM IST) and ends on Monday, 28th September, 2026 (05.00 PM IST).

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Cohance Lifesciences informs about update

Cohance Lifesciences has informed that the United States Food and Drug Administration (USFDA) inspected the Company’s API manufacturing facility at Jaggaiahpet, Andhra Pradesh, India (FEI No. 3005554260), from 14 September to 19 September 2026. The inspection concluded with the issuance of a Form FDA 483 containing five observations. The Company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. The Company remains committed to quality and regulatory compliance.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

The inspection concluded with the issuance of a Form FDA 483 containing five observations

Sep, 2026

Biocon informs about press release

Biocon has informed that it enclosed the press release titled ‘Biocon’s Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics has informed regarding the voting results as the outcome of the postal ballot dated September 17, 2026.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Gennex Laboratories Ltd.	250 Crore
2	Take Ltd.	238 Crore
3	Syncom Formulations (India) Ltd.	1,882 Crore
4	Anlon Healthcare Ltd.	1,219 Crore
5	Sigachi Industries Ltd.	1,130 Crore
6	Fischer Medical Ventures Ltd.	2,320 Crore
7	Medico Remedies Ltd.	291 Crore
8	Ambalal Sarabhai Enterprises Ltd.	310 Crore
9	Shukra Pharmaceuticals Ltd.	2,467 Crore
10	Anuh Pharma Ltd.	936 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,959	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,019	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,696	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,405	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,464	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,214	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Park Medi World informs about press release

One Global Service Provider informs about corrigendum to AGM notice

Cohance Lifesciences informs about update

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

Biocon informs about press release

Krsnaa Diagnostics informs about updates

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?